Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theresa Barnes

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
BMJ (Clinical Research Ed.)|May 6, 2025
The outpatient model in the NHS is not just creaking-it is collapsingTheresa Barnes
Future Healthcare Journal|February 3, 2026
Enduring symptoms: A call to immediate actionTheresa Barnes
International Journal of Nanomedicine|August 29, 2007
Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegolTheresa Barnes, Robert Moots
BMJ (Clinical Research Ed.)|September 18, 2023
New and follow-up outpatient appointments are out of date conceptsJohn Dean, Theresa Barnes
Cytokine|September 29, 2005
Cytokine medicines in clinical practice: current issuesTheresa Barnes, Robert J Moots, John Goodacre
Expert Opinion on Biological Therapy|August 27, 2005
Second International Conference on Cytokine MedicinesTheresa Barnes, John Goodacre, Robert J Moots
Cytokine|September 29, 2006
Therapeutic targeting of cytokinesTheresa Barnes, John Goodacre, Robert J Moots
Journal of Nursing Management|February 5, 2026
Transitioning of Registered General Nurses to Nurse Managers-A Quantitative Study in the Greater Accra Region of GhanaDocia Baah, Theresa Barnes, Adelaide Maria Ansah Ofei
Future Healthcare Journal|May 27, 2020
The value of embedded secondary-care-based psychology services in rheumatology: an exemplar for long-term conditionsTheresa Barnes, Lou Taylor, Charlotte Eost-Telling, et al.
Rheumatology (Oxford, England)|October 17, 2015
A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitorSurabhi Wig, Marian Chan, Jecko Thachil, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
BMJ (Clinical Research Ed.)|May 6, 2025
The outpatient model in the NHS is not just creaking-it is collapsingTheresa Barnes
Future Healthcare Journal|February 3, 2026
Enduring symptoms: A call to immediate actionTheresa Barnes
International Journal of Nanomedicine|August 29, 2007
Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegolTheresa Barnes, Robert Moots
BMJ (Clinical Research Ed.)|September 18, 2023
New and follow-up outpatient appointments are out of date conceptsJohn Dean, Theresa Barnes
Cytokine|September 29, 2005
Cytokine medicines in clinical practice: current issuesTheresa Barnes, Robert J Moots, John Goodacre
Expert Opinion on Biological Therapy|August 27, 2005
Second International Conference on Cytokine MedicinesTheresa Barnes, John Goodacre, Robert J Moots
Cytokine|September 29, 2006
Therapeutic targeting of cytokinesTheresa Barnes, John Goodacre, Robert J Moots
Journal of Nursing Management|February 5, 2026
Transitioning of Registered General Nurses to Nurse Managers-A Quantitative Study in the Greater Accra Region of GhanaDocia Baah, Theresa Barnes, Adelaide Maria Ansah Ofei
Future Healthcare Journal|May 27, 2020
The value of embedded secondary-care-based psychology services in rheumatology: an exemplar for long-term conditionsTheresa Barnes, Lou Taylor, Charlotte Eost-Telling, et al.
Rheumatology (Oxford, England)|October 17, 2015
A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitorSurabhi Wig, Marian Chan, Jecko Thachil, et al.
Pageof 3